Erratum: Impact of the M184V/I mutation on the efficacy of abacavir/lamivudine/dolutegravir therapy in HIV treatment-experienced patients (Open Forum Infectious Diseases (2019) 6: 10 (ofz330) DOI: 10.1093/ofid/ofz330)

Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, Sabine Yerly, Gilles Wandeler, Marcel Stoeckle, Matthias Cavassini, Alexandra Scherrer, Dominique Costagliola, Patrick Schmid, Huldrych F. Günthard, Enos Bernasconi, Jürg Boeni, Antonella D’Arminio Monforte, Maurizio Zazzi, Barbara Rossetti, Didier Neau, Pantxika Bellecave, Bart Rijnders, Peter ReissFerdinand Wit, Roger Kouyos, Alexandra Calmy

Research output: Contribution to journalComment/Letter to the editorPopular

15 Downloads (Pure)

Abstract

In “Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients” Open Forum Infectious Diseases, Volume 6, Issue 10, October 2019, ofz330, https://doi.org/10.1093/ofid/ofz330, the surname of a co-author, Dominique Costagliola, was misspelled. This was corrected in the new version of the manuscript.

Original languageEnglish
JournalOpen Forum Infectious Diseases
Volume6
Issue number12
DOIs
Publication statusPublished - 8 Dec 2019

Bibliographical note

Publisher Copyright:
© The Author(s) 2019.

Fingerprint

Dive into the research topics of 'Erratum: Impact of the M184V/I mutation on the efficacy of abacavir/lamivudine/dolutegravir therapy in HIV treatment-experienced patients (Open Forum Infectious Diseases (2019) 6: 10 (ofz330) DOI: 10.1093/ofid/ofz330)'. Together they form a unique fingerprint.

Cite this